BILOBA is a STREP collaborative project funded by the European Commission through its Seventh Framework Programme. The acronym is an abbreviation of Bloch electromagnetic surface wave bio-sensors for early cancer diagnosis.
BILOBA plans to develop and pre-clinically validate a multifunctional point-of-care platform that is capable of performing real-time cancer biomarker detection in a tandem configuration. Such configuration will utilise the well-known label-free detection based on the resonance shift, and the spectral analysis of enhanced fluorescence emitted by biomolecules immobilized on the surface. Utilizing both labeled and label-free analysis on the same sensor system can increase the sensitivity and reliability of optically read-out surface bound assays.